<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://phleb.rsmjournals.com">
<title>Phlebology recent issues</title>
<link>http://phleb.rsmjournals.com</link>
<description>Phlebology RSS feed -- recent issues</description>
<prism:publicationName>Phlebology</prism:publicationName>
<prism:issn>0268-3555</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/251?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/252?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/259?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/276?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/287?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/295?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/6/299?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/203?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/206?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/214?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/222?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/227?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/230?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/249?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/5/250?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/147?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/149?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/158?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/172?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/178?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/184?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/189?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/193?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/4/196?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/101?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/103?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/112?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/118?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/120?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/125?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/130?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/137?rss=1" />
  <rdf:li rdf:resource="http://phleb.rsmjournals.com/cgi/content/short/23/3/142?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/251?rss=1">
<title><![CDATA[Patient-reported outcome or physician-reported outcome?]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/251?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Guex, J.-J.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008067</dc:identifier>
<dc:title><![CDATA[Patient-reported outcome or physician-reported outcome?]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>251</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>251</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/252?rss=1">
<title><![CDATA[Thigh compression]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/252?rss=1</link>
<description><![CDATA[
<p>The aim of this overview is to discuss the role of thigh compression for the management of venous and lymphatic diseases. The most important indications for thigh compression are prevention and treatment of sequelae of superficial vein procedures (surgery or endovenous procedures), prevention and therapy of deep vein thrombosis (DVT), post-thrombotic syndrome and lymphoedema. The intended effects depend mainly on narrowing/occlusion of deep and superficial veins on which the body position and the applied pressure play a crucial role. While in the horizontal position thigh veins can be narrowed by the light pressure of a thromboprophylactic stocking, much higher pressure is needed to compress thigh veins effectively during standing and walking. This is shown by magnetic resonance imaging (MRI) performed in the supine and upright position. Using pads, rolls or specially designed devices, the local pressure under conventional compression garments or bandages over a treated vein can be increased considerably. In patients with deep valve incompetence, beneficial haemodynamic effects of strong thigh compression have been demonstrated, but clinical studies in this field are still lacking. Thigh compression reduces oedema in patients with DVT and lymphoedema.</p>
]]></description>
<dc:creator><![CDATA[Partsch, H, Mosti, G]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008053</dc:identifier>
<dc:title><![CDATA[Thigh compression]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>258</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>252</prism:startingPage>
<prism:section>Venous Disease A-Z series: no. 7</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/259?rss=1">
<title><![CDATA[Venous Clinical Severity Score and quality-of-life assessment tools: application to vein practice]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/259?rss=1</link>
<description><![CDATA[
<p>The time is ripe for universal understanding and acceptance of outcome assessment in venous disease. Outcome studies promote understanding of the diseases we treat and the results of treatment. The choice of a valid and reliable assessment tool is crucial. Patient-generated quality-of-life tools include generic instruments and disease-specific instruments. Generic instruments evaluate overall well-being and provide subjective measurements of treatment outcomes in various disease states. The 36-Item Short Form Health Survey and the Nottingham Health Profile are widely used generic surveys. Disease-specific instruments relate to a particular disease state. They are popular in venous disease reporting and have high sensitivity. The Chronic Venous Insufficiency Questionnaire, the Venous Insufficiency Epidemiological and Economic Study, the Aberdeen Varicose Vein Questionnaire and the Charing Cross Venous Ulceration Questionnaire are such devices. Physician-generated measurement tools are used to evaluate and classify the consequences of venous disease. The clinical, aetiology, anatomy, pathophysiology classification (CEAP) is a popular descriptive platform for chronic venous disease. The Venous Severity Scoring (VSS) system was derived from the CEAP classification to provide evaluative capabilities. The three elements of the VSS are the venous disability score, the venous segmental disease score and the venous clinical severity score (VCSS). The VCSS facilitates the follow-up of features of venous disease that change with treatment. Each of these outcomes tools has been validated, and each has strengths and weaknesses. Maintaining the dynamic nature of assessment with periodic review and revision is the way forward to generating universal applicability. Although the choice of instrument is debatable, the most important factor in improving treatment outcomes is the decision to examine results and to share them in a meaningful way.</p>
]]></description>
<dc:creator><![CDATA[Vasquez, M A, Munschauer, C E]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008018</dc:identifier>
<dc:title><![CDATA[Venous Clinical Severity Score and quality-of-life assessment tools: application to vein practice]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>275</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>259</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/276?rss=1">
<title><![CDATA[Diagnosis and therapy in children with lymphoedema]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/276?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Lymphoedema (LE) is a disorder characterized by persistent swelling caused by impaired lymphatic drainage because of various aetiologies, including lymphatic injury and congenital functional or anatomical defects.</p>
</sec>
<sec><st>Objective</st>
<p>Literature review and expert opinion about diagnosis and treatment of LE in children.</p>
</sec>
<sec><st>Results</st>
<p>LE is rare in children, with a prevalence of about 1.15/100,000 persons, 20 years old. The management of LE in children differs considerably from adults in terms of origin, co-morbidity and therapeutic approach. The objective of this presentation is to discuss practical issues related to clinically relevant information on the diagnosis, aetiology, work-up and treatment of LE in children. In contrast to adults, who usually experience secondary LE because of acquired lymphatic failure, most cases in children have a primary origin. The diagnosis can be made mainly on the basis of careful personal and family history, and physical examination. LE in children can be part of a syndrome if there are other concomitant phenotypic abnormalities and if a genetic defect is recognizable. Treatment of LE is mostly conservative utilizing decongestive LE therapy including compression therapy, directed exercises, massage and skincare. In the neonate, initial observation alone may be sufficient, as delayed lymphatic development and maturation can result in spontaneous improvement. The role of parents is crucial in providing the necessary input.</p>
</sec>
<sec><st>Conclusion</st>
<p>We present a review emphasizing a practical approach to treating a child with LE according to current publications and our own experience.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Damstra, R J, Mortimer, P S]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008010</dc:identifier>
<dc:title><![CDATA[Diagnosis and therapy in children with lymphoedema]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>286</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>276</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/287?rss=1">
<title><![CDATA[Inelastic compression increases venous ejection fraction more than elastic bandages in patients with superficial venous reflux]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/287?rss=1</link>
<description><![CDATA[
<sec><st>Aim</st>
<p>To investigate the influence of compression bandages, manufactured using materials with different elastic properties, on the impaired venous pumping function in patients with venous insufficiency.</p>
</sec>
<sec><st>Methods</st>
<p>Ejection volume (EV) and ejection fraction (EF) were measured using strain gauge plethysmography distal from the patella without and with elastic and inelastic compression bandages in a total of 30 patients with major venous reflux in the great saphenous vein. The interface pressure of the bandages was measured simultaneously in the medial gaiter area. Normal values of EV and EF were obtained from 15 healthy controls.</p>
</sec>
<sec><st>Results</st>
<p>Patients with venous insufficiency showed a statistically significant reduction of EV and EF compared to controls. Elastic bandages with an average pressure of 42 mm Hg in the supine position achieved a moderate increase of EV and a significant improvement of EF (p &lt; .01), while inelastic bandages applied with comparable resting pressure (41 mm Hg) raised EV and EF into a normal range (p &lt; .001). The improvement of the ejection fraction correlates well with the pressure differences between standing and lying (Static Stiffness Index) and between muscle systole and diastole during exercise (Pearson r = 0.69 and 0.74 respectively, p &lt; .001). Elastic bandages applied with high stretch in order to achieve standing pressures comparable to those of inelastic bandages (&gt;60 mm Hg) led only to a minor improvement of the venous pumping function.</p>
</sec>
<sec><st>Conclusions</st>
<p>Ejected volume and ejection fraction, which are severely reduced in venous insufficiency, can be increased by compression therapy. Inelastic compression is much more effective than elastic bandages, and is able to normalize venous pumping function. With elastic bandages EV and EF always remain below the normal range even when applied with high stretch producing a resting pressure that is barely tolerable.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Mosti, G, Mattaliano, V, Partsch, H]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008009</dc:identifier>
<dc:title><![CDATA[Inelastic compression increases venous ejection fraction more than elastic bandages in patients with superficial venous reflux]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>294</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>287</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/295?rss=1">
<title><![CDATA[Transilluminated powered phlebectomy: a clinical report]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/295?rss=1</link>
<description><![CDATA[
<p>Twenty-one patients with varicose vein incompetence of the legs have been treated with the TriVex system (Smith &amp; Nephew, Andover, MA, USA). The technique is designed for treatment of local varicosities to provide a good cosmetic result (remaining varicosities and pigmentation) and less morbidity (pain and loss of work days). These parameters showed good results with few remaining varicosities and pigmentations. Reasonable number of days out of work and moderate pain. Eighteen of the 21 patients had an overall good outcome with no complaints.</p>
]]></description>
<dc:creator><![CDATA[Akesson, H]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008003</dc:identifier>
<dc:title><![CDATA[Transilluminated powered phlebectomy: a clinical report]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>298</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>295</prism:startingPage>
<prism:section>Short Report</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/6/299?rss=1">
<title><![CDATA[Treatment of superficial thrombophlebitis of the great saphenous vein]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/6/299?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[De Maeseneer, M.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008034</dc:identifier>
<dc:title><![CDATA[Treatment of superficial thrombophlebitis of the great saphenous vein]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>299</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>299</prism:startingPage>
<prism:section>Letter</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/203?rss=1">
<title><![CDATA[Compression therapy in venous disease]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/203?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Blattler, W, Zimmet, S E]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.081004</dc:identifier>
<dc:title><![CDATA[Compression therapy in venous disease]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>205</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>203</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/206?rss=1">
<title><![CDATA[Endovenous laser ablation: mechanism of action]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/206?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The objective of this study is to review the basics of laser and established tissue response patterns to thermal injury, with specific reference to endovenous laser ablation (EVLA). This study also reviews the current theories and supporting aspects for the mechanism of action of EVLA in the treatment of superficial venous reflux.</p>
</sec>
<sec><st>Methods</st>
<p>The method involves the review of published literature and original investigation of histological effects of 810 nm and 980 nm wavelength EVLA on explanted blood-filled bovine saphenous vein in an <I>in vitro</I> system.</p>
</sec>
<sec><st>Results</st>
<p>The existing histological reports confirm that EVLA produces a transmural vein wall injury, typically associated with perforations and carbonization. The pattern of injury is eccentrically distributed, with maximum injury occurring along the path of laser contact. Intravenous temperature monitoring studies during EVLA have confirmed that the peak temperatures at the fibre tip exceed 1000&deg;C, and continuous temperatures of at least 300&deg;C are maintained in the firing zone for the majority of the procedure. Steam production during EVLA, which occurs early in the photothermolytic process when temperatures reach 100&deg;C, accounts for only 2% of applied energy dose, and is therefore unlikely to be the primary mechanism of action of thermal injury during the procedure.</p>
</sec>
<sec><st>Conclusion</st>
<p>EVLA causes permanent vein closure through a high-temperature photothermolytic process at the point of contact between the vein and the laser.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Fan, C-M, Rox-Anderson, R]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008049</dc:identifier>
<dc:title><![CDATA[Endovenous laser ablation: mechanism of action]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>213</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>206</prism:startingPage>
<prism:section>Venous Disease A-Z series: no. 6</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/214?rss=1">
<title><![CDATA[Leg symptoms of healthy people and their treatment with compression hosiery]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/214?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Occasional leg symptoms, like feelings of heaviness and tension, and occupational or evening oedema are considered typical features of a venous disorder but show low specificity in epidemiological and observational studies. We evaluated the prevalence and nature of such symptoms in subjects with no history or signs of venous disease and investigated the optimal strength that medical compression stockings (MCS) should exert in order to alleviate the symptoms and to prevent leg swelling.</p>
</sec>
<sec><st>Methods</st>
<p>Specifically designed questionnaires were used to assess the symptoms of 40 healthy employees of a factory producing MCS. Lower leg volumes were quantified in the morning and evening. Calf size hosiery providing documented ankle pressures of 4&ndash;9 (mean 7.3), 12&ndash;18 (mean 14.9) and 18&ndash;22 (mean 19.5) mmHg, respectively, were tested in a prospective, open-label, randomized trial lasting three weeks. Endpoints were the relief of symptoms, prevention of vesperal oedema and comfort in wearing the stockings.</p>
</sec>
<sec><st>Results</st>
<p>Sixty-five percent of the participants reported at least occasional leg symptoms and oedema. Somatic-type symptoms (i.e. pain, heaviness, swelling, unattractive legs) were present in two, psychic-type symptoms (i.e. leg- and personality-related unrest and stress) in 17 and both components in seven of the 40 subjects. MCS exerting 15 and 20 mmHg prevented the symptoms and oedema. Stockings providing &lt;10 mmHg were ineffective and those providing &gt;19 mmHg were not well-tolerated. The effect on the somatic-type symptoms was strongly correlated with the amount of lower leg volume which could be reduced by wearing stockings (<I>P</I> = 0.005). No correlation was found between the efficacy of compression and the emotional component of the symptoms.</p>
</sec>
<sec><st>Conclusion</st>
<p>The cause of occasional pain in the legs of apparently healthy people is unknown. Some features of the syndrome reflect an emotional disorder while others mirror venous insufficiency. MCS of 15 mmHg effectively relieve the symptoms resembling venous insufficiency, prevent oedema and are well-tolerated.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Blattler, W, Kreis, N, Lun, B, Winiger, J, Amsler, F]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008014</dc:identifier>
<dc:title><![CDATA[Leg symptoms of healthy people and their treatment with compression hosiery]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>221</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>214</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/222?rss=1">
<title><![CDATA[The effect of nitroglycerin ointment on great saphenous vein targeted venous access site diameter with endovenous laser treatment]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/222?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To assess the effect of topically applied nitroglycerin (NTG) ointment (2%) on preoperative targeted venous access site great saphenous vein (GSV) diameter in patients undergoing endovenous laser treatment (ELT).</p>
</sec>
<sec><st>Methods</st>
<p>In this double-blinded randomized study design, 75 patients received either (A) treadmill ambulation only, (B) topically applied NTG ointment only, or (C) topically applied NTG ointment + treadmill ambulation. Targeted venous access vein diameters were measured before therapeutic intervention and then repeated after approximately 30 min following pretreatment intervention. Presence of venospasm and the number of ultrasound-guided venous access attempts during each ELT procedure were assessed during the study.</p>
</sec>
<sec><st>Results</st>
<p>The mean pretreatment vein diameter was 2.6 mm (range 0.9&ndash;4.9 mm). The post-treatment percentage change in vein diameter for group A (treadmill ambulation only) was +2.7% (<I>P</I> = 0.403), whereas group B (NTG only) and group C (NTG + treadmill ambulation) demonstrated significant venodilatation of +69.0% (<I>P</I> &lt; 0.0001) and +51.7% (<I>P</I> &lt; 0.0001), respectively. Statistical analysis of variances and multivariate linear regression model revealed topically applied NTG ointment and &lsquo;C&rsquo; classification of clinical, aetiological, anatomical and pathological elements (CEAP) were each significant predictors for venodilatation percentage change (<I>P</I> &lt; 0.001 and = 0.028, respectively).</p>
</sec>
<sec><st>Conclusion</st>
<p>Pretreatment with topically applied NTG ointment (2%) produced a statistically significant, as well as subjective clinically significant venodilatation change in the targeted venous access site diameter of patients undergoing ELT of the GSV in this study.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hogue, R S, Schul, M W, Dando, C F, Erdman, B E]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007076</dc:identifier>
<dc:title><![CDATA[The effect of nitroglycerin ointment on great saphenous vein targeted venous access site diameter with endovenous laser treatment]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>226</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>222</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/227?rss=1">
<title><![CDATA[The use of autologous femoral vein for the repair of the common iliac vein after resection of a pheochromocytoma]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/227?rss=1</link>
<description><![CDATA[
<sec><st>Aim</st>
<p>To illustrate the use of autologous femoral vein for grafting ilio-caval vein defects following abdomino-pelvic tumour resections.</p>
</sec>
<sec><st>Methods</st>
<p>Case report and literature review.</p>
</sec>
<sec><st>Results</st>
<p>Durable restoration of ilio-caval patency was achieved, with minimal morbidity from graft harvesting.</p>
</sec>
<sec><st>Conclusions</st>
<p>Autologous femoral vein presents a viable graft option for the immediate reconstruction of large intra-abdominal vein deficits.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Simms, M, Mehat, M S, Buckels, J A C]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.007081</dc:identifier>
<dc:title><![CDATA[The use of autologous femoral vein for the repair of the common iliac vein after resection of a pheochromocytoma]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>229</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Short Report</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/230?rss=1">
<title><![CDATA[Report on the Ninth Meeting of the European Venous Forum: Barcelona, Spain, 26-28 June 2008]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/230?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kalodiki, E, on behalf of the Scientific Committee, Nicolaides, A., Lurie, F., Schmid-Schonbein, G. W, Bergan, J. J, Jawien, A., Lurie, F, Kistner, R., Ly, C, Akamine, J, Partsch, H, Vanscheidt, W, Ukat, A, Mosti, G, Mattaliano, V, Partsch, H, Jawien, A, Szewczyk, M., Moscicka, P, Cierzniakowska, K, Cwajda, J, Pittaluga, P, Chastanet, S, Rea, B, Barbe, R, Guex, J-J, Paolini, D, Jones, L, Comerota, A., Martinez, J, Comerota, A., Kazanjian, S, DiSalle, R, Sepanski, D., Assi, Z., Tacconi, G, Menegatti, E, Fortini, P, Legnaro, A, Gianesini, S, Zamboni, P, Ruiz, E M., Villegas, A R., Espi, M S., Castellote, M. C., Gasparis, A., Labropoulos, N, Pefanis, D, Leon, L., Psalms, S., Tassiopoulos, A., Rabe, E, Pannier, F, Geier, B, Mumme, A, Hummel, T, Marpe, B, Freis, H, Stucker, M, Asciutto, G, Delis, K., Gloviczki, P, Wennberg, P, Bjarnason, H, Rooke, T, Driscoll, D., Shepherd, A., Gohel, M., Hamish, M, Lim, C., Davies, A., Romera-Villegas, A, Vila-Coll, R, Cairols, M, Martinez-Rico, C, Kowalewski, R, Malkowski, A, Sobolewski, K, Gacko, M, Carpentier, P., Widmer, M-T, Zemp, E, Uhl, J-F, Cornu-Thenard, A, Goode, S, Crockett, M, Richards, T, Braithwaite, B, Chowdhury, A, King, T., van den Bos, R, Kockaert, M, Neumann, N, Nijsten, T, Kalodiki, E, Azzam, M, Kakkos, S., Zambas, N, Bountouroglou, D, Geroulakos, G, Pares, O, Juan, J, Moreno, C, Tellez, R, Codony, I, Mata, A, Quer, X, Roca, J, Vuylsteke, M, Van Dorpe, J, Roelens, J, Mordon, S, Hamel-Desnos, C. M, Guias, B, Quehe, P, Mesgard, A, Desnos, P, Ferre, B, Le Querrec, A, Gillet, J-L, Guedes, J., Guex, J-J, Hamel-Desnos, C, Schadeck, M, Lauseker, M, Allaert, F., Trinidad, V M., Trinidad, H M., Villavicencio, J L., Gohel, M., Shepherd, A, Lim, C., Hamish, M, Davies, A., Uncu, H]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.081003</dc:identifier>
<dc:title><![CDATA[Report on the Ninth Meeting of the European Venous Forum: Barcelona, Spain, 26-28 June 2008]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>248</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>230</prism:startingPage>
<prism:section>European Venous Forum Abstracts</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/249?rss=1">
<title><![CDATA[Letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/249?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Guex, J-J, Raymond-Martimbeau, P, Simka, M, Passariello, F]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008031</dc:identifier>
<dc:title><![CDATA[Letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>249</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>249</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/5/250?rss=1">
<title><![CDATA[Reply to letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/5/250?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ceulen, R P M, Vernooy, K]]></dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008035</dc:identifier>
<dc:title><![CDATA[Reply to letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>250</prism:endingPage>
<prism:publicationDate>2008-10-01</prism:publicationDate>
<prism:startingPage>250</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/147?rss=1">
<title><![CDATA[Is there still a role for basic science research in venous disease?]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/147?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Lim, C S, Gohel, M S, Davies, A H]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.081002</dc:identifier>
<dc:title><![CDATA[Is there still a role for basic science research in venous disease?]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>148</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>147</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/149?rss=1">
<title><![CDATA[Chronic deep venous obstruction: definition, prevalence, diagnosis, management]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/149?rss=1</link>
<description><![CDATA[
<p>Ilio-caval venous obstruction has an important role in the expression of symptomatic chronic venous disease regardless of aetiology. The presence of obstruction has been more or less previously ignored and emphasis placed on reflux alone. Stenting of the ilio-femoral veins guided by intravascular ultrasound (IVUS) can now be performed with low morbidity and mortality using appropriate technique. Current diagnostic modalities do not allow a definitive assessment of haemodynamically critical venous obstruction, which hampers selection of limbs for treatment. The diagnosis must be based on morphological studies (preferably IVUS) in patient selected with specific history, signs and symptoms. A high index of suspicion and generous use of morphological investigations are critical in the initial recognition of venous outflow obstruction. Stenting of the ilio-femoral vein appears to be durable with a substantial improvement in limb pain and swelling, high rate of ulcer healing, enhanced quality of life and decreased disability. The beneficial clinical outcome occurs regardless of the presence of remaining reflux, adjunct saphenous procedures or aetiology of obstruction.</p>
]]></description>
<dc:creator><![CDATA[Neglen, P.]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008027</dc:identifier>
<dc:title><![CDATA[Chronic deep venous obstruction: definition, prevalence, diagnosis, management]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>157</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>149</prism:startingPage>
<prism:section>Venous Disease A-Z series: no. 5</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/158?rss=1">
<title><![CDATA[Monocusp - novel common femoral vein monocusp surgery uncorrectable chronic venous insufficiency with aplastic/dysplastic valves]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/158?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Previous reparative valvular surgical options directed at reconstructing damaged common femoral vein (CFV) valves associated with pathological chronic venous insufficiency (CVI) have not succeeded in reliably managing CVI. In consequence, venous valvuloplasty is rare and most patients are managed conservatively. As a result, monocusp surgery was identified as an optional surgical solution for this large underserved patient group.</p>
</sec>
<sec><st>Methods</st>
<p>Ulcer patients appear at wound clinics and often experience disappointing results. Monocusp valves were constructed utilizing viable vein wall in 14 operations on 11 patients. These patients were observed for four years to see if such an autogenous vein wall valve might control aggressive symptomatic CVI when faced with unusable valves.</p>
</sec>
<sec><st>Results</st>
<p>Long-term follow-up showed that the monocusp valves remained competent at four years. Symptomatic failures have not appeared at this time. Pain, swelling, ulcers and leg congestion were reliably reversed. VEnous INsufficiency Epidemiologic and Economic Study (VEINES) classification (see Abenhaim L, Krux X, VIENES Study collaborators. <I>Angiology</I> 1997;<b>48</b>:59 and Kurz X, Kahn SR, Abenhaim L, <I>et al.</I> <I>Int Angiol</I> 1999;<b>18</b>:83&ndash;102) improved over four years from 2.7 &plusmn; 0.9 to 0 (<I>P</I> &lt; 0.001); CEAP classifications (see Kistner RL, Eklof B, Masuda EM. <I>Mayo Clin Proc</I> 1996;<b>71</b>:338&ndash;45) improved from grade 4&ndash;6 to 0&ndash;1 (CEAP is not generally a postoperative grading system, but it can be used to develop some form of qualitative analyses as to intervention effectiveness, i.e. what existed preoperatively no longer exists postoperatively. Its postsurgery use is limited by (C5) classification &ndash; history of ulcer, which by definition cannot go below that with a history of ulcer even if the ulcer has been cured). Mean venous reflux scores decreased from 3.8 &plusmn; 0.4 to 0.3 &plusmn; 0.5 (<I>P</I> &lt; 0.001).</p>
</sec>
<sec><st>Conclusion</st>
<p>Monocusp implantation reliably resolved patient symptoms when unusable CFV valves were encountered. Postoperative CFV reflux is usually undetectable. The monocusp valve exhibits minimal thrombogenicity related to its viability with attendant antithrombotic hormone production capacity and has markedly improved the patient's quality of life. Full thickness monocusp surgery could become widespread with the difficult dysplastic/aplastic CVI patient subset because of its simplicity, repeatability, durability, low complication rate, effectiveness, persistent availability and viability providing nitric oxide synthase and thymomodulin hormone production capacity. The full thickness of vein wall has distinct advantages over other partial thickness valve creation methods because of its long-term vitality. Postoperative coumadin is recommended for six months to minimize risks of deep vein thrombosis and/or pulmonary embolism.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Opie, J C, Izdebski, T, Payne, D N, Opie, S R]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007075</dc:identifier>
<dc:title><![CDATA[Monocusp - novel common femoral vein monocusp surgery uncorrectable chronic venous insufficiency with aplastic/dysplastic valves]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>171</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>158</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/172?rss=1">
<title><![CDATA[Combined endovenous laser treatment and ambulatory phlebectomy for the treatment of saphenous vein incompetence]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/172?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The aim of this retrospective study is to assess the safety and effectiveness of endovenous laser treatment (EVLT) combined with ambulatory phlebectomy (AP) as a single procedure for treating saphenous vein incompetence.</p>
</sec>
<sec><st>Methods</st>
<p>The study enrolled 148 patients with saphenofemoral or saphenopopliteal junction reflux associated with saphenous vein incompetence and enlarged branch veins. Patients were treated with EVLT (135 great saphenous veins, 41 small saphenous veins) concomitantly with AP as a single procedure. All patients were followed up by clinical assessment and duplex ultrasound at one week and 12 weeks after the procedure.</p>
</sec>
<sec><st>Results</st>
<p>No postprocedural deep vein thrombosis and pulmonary embolism occurred. Saphenous vein recanalization rate at three months was 5.7%. Residual varicosities were found in 11.4% of the patients at three months after procedure, but only 2.3% of those required subsequent interventions.</p>
</sec>
<sec><st>Conclusion</st>
<p>Combined EVLT and AP could be a safe and effective treatment modality for the saphenous vein incompetence.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Jung, I M, Min, S I, Heo, S C, Ahn, Y J, Hwang, K-T, Chung, J K]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008002</dc:identifier>
<dc:title><![CDATA[Combined endovenous laser treatment and ambulatory phlebectomy for the treatment of saphenous vein incompetence]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>177</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>172</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/178?rss=1">
<title><![CDATA[The use of therapeutic ultrasound in venous leg ulcers: a randomized, controlled clinical trial]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/178?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To estimate the usefulness of therapeutic ultrasound for healing of venous leg ulcers.</p>
</sec>
<sec><st>Methods</st>
<p>Eighty-one patients were included in this study. Patients in groups 1 and 2 were treated surgically. Patients in groups 3 and 4 were treated conservatively. Patients in groups 1 and 3 were additionally treated with the ultrasound (1 MHz, 0.5 W/cm<sup>2</sup>) once daily, six times a week for seven weeks.</p>
</sec>
<sec><st>Results</st>
<p>Comparison of the number of complete healed wounds indicated statistically significant differences between groups 1 and 4 (<I>P</I> = 0.03), 2 and 4 (<I>P</I> = 0.03), 3 and 4 (<I>P</I> = 0.03) in favour of groups 1, 2 and 3. Comparison of the other parameters also demonstrated more efficient therapy effects in groups 1, 2 and 3 than in group 4. There were no statistical differences in all examined parameters between groups 1, 2 and 3 (<I>P</I> &gt; 0.05).</p>
</sec>
<sec><st>Conclusions</st>
<p>The ultrasound is an efficient and useful method only in conservatively treated venous leg ulcers. There are no special reasons for application of the ultrasound in surgically treated patients. A well-conducted surgical operation is much more effective for a healing process than conservative pharmacological procedures.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Taradaj, J, Franek, A, Brzezinska-Wcislo, L, Cierpka, L, Dolibog, P, Chmielewska, D, Blaszczak, E, Kusz, D]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008015</dc:identifier>
<dc:title><![CDATA[The use of therapeutic ultrasound in venous leg ulcers: a randomized, controlled clinical trial]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>183</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>178</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/184?rss=1">
<title><![CDATA[Aneurysm of the inferior vena cava: case report and review of the literature]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/184?rss=1</link>
<description><![CDATA[
<p>Aneurysms of the inferior vena cava (IVC) are extremely rare. To the best of our knowledge, only 29 cases of IVC aneurysms are published in literature. We present a new case of surgically treated symptomatic saccular aneurysm of the infrarenal IVC and review previously published cases. Following resection of the aneurysm and the thrombosed infrarenal IVC, the patient fully recovered. Thrombosed IVC aneurysm may mimic a retroperitoneal tumour. In some cases, CT and MRI findings may be equivocal. Surgical treatment is indicated in all symptomatic and low-risk asymptomatic cases.</p>
]]></description>
<dc:creator><![CDATA[Davidovic, L, Dragas, M, Bozic, V, Takac, D]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.008008</dc:identifier>
<dc:title><![CDATA[Aneurysm of the inferior vena cava: case report and review of the literature]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>188</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>184</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/189?rss=1">
<title><![CDATA[Major neurological events following foam sclerotherapy]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/189?rss=1</link>
<description><![CDATA[
<sec><st>Aim</st>
<p>This report describes two complications of severe neurologic alterations (TIA, CVA) after foamed sclerotherapy injection.</p>
</sec>
<sec><st>Methods</st>
<p>Using foam sclerotherapy in accepted concentrations, volume, and in standard ratio of air to sclerosant, two serious neurologic complications occurred.</p>
</sec>
<sec><st>Results</st>
<p>In both cases described, unknown atrial communications existed resulting in foam emboli. One case involving the vertebral system resolved without treatment. The other involving the cerebral system was treated with hyperbaric oxygen.</p>
</sec>
<sec><st>Conclusions</st>
<p>Foam sclerotherapy can cause serious neurologic phenomenon even though the incidence is rarely described. Immediate treatment with 100% O2 and possible hyperbaric O2 therapy should be considered.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bush, R G, Derrick, M, Manjoney, D]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007073</dc:identifier>
<dc:title><![CDATA[Major neurological events following foam sclerotherapy]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>192</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>189</prism:startingPage>
<prism:section>Short Reports</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/193?rss=1">
<title><![CDATA[Endovenous laser ablation for persistent and recurrent venous ulcers after varicose vein surgery]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/193?rss=1</link>
<description><![CDATA[
<p>A 75-year-old woman presented with painful recurrent venous ulcers (VU) continuously for the past 33 months on a background of frequent intermittent problems for the last 16 years. She had previously been treated with varicose vein surgery and trials of compression bandaging. Subsequently, she underwent endovenous laser ablation (EVLA) targeting the distal incompetent remnant of her great and small saphenous veins. This resulted in complete healing of her ulcers within four weeks. The dramatic response demonstrated in this case suggests that EVLA may represent an effective intervention in the management of postsurgery refractory VU.</p>
]]></description>
<dc:creator><![CDATA[Kambal, A A, De'Ath, H D, Albon, H, Watson, A, Shandall, A, Greenstein, D]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.006044</dc:identifier>
<dc:title><![CDATA[Endovenous laser ablation for persistent and recurrent venous ulcers after varicose vein surgery]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>195</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>193</prism:startingPage>
<prism:section>Short Reports</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/4/196?rss=1">
<title><![CDATA[Spring meeting of the Venous Forum at The Royal Society of Medicine, 3-4 April 2008]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/4/196?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Theivacumar, N S, Stead, L, Mavor, A I D, Gough, M J, O'Hare, J L, Campbell, W B, Earnshaw, J J, (on behalf of the JVRG), Goode, S, Crockett, M, Richards, T, Braithwaite, B, Moffat, C E, Bhogal, R, Nyamekye, I K, O'Hare, J L, Campbell, W B, Earnshaw, J J, (on behalf of the JVRG), Crockett, M, Goode, S, Braithwaite, B, Richards, T, Mackenzie, R, Brittenden, J, Bachoo, P, Balakrishnan, A, Mylankal, K, Nalachandran, S, Subramonia, S, Lees, T, Shepherd, A C, Gohel, M S, Hamish, M, Davies, A H, Gohel, M S, Hamish, M, Shepherd, A, Davies, A H, Marsh, P, Price, B A, Holdstock, J M, Harrison, C, Smith, C, Whiteley, M S, Saha, P, Chinien, G, Burnand, K., Waltham, M, Ahmad, Z, Campbell, B, Horwood, J, Watkinson, T, Kinsella, D, Thompson, J, Cowan, A, Winterborn, R J, Kinsella, D C, Watkinson, A F, Thompson, J., Kanwar, A, Hansrani, M, Lees, T, Stansby, G, Hamish, M, Baker, C, Gohel, M, Shepherd, A, Davies, A H, Bhogal, R, Moffat, C E, Coney, P M, Nyamekye, I K, Buckley, K A, de Cossart, L, Edwards, P, Dimitri, S, Chase, L, Holdstock, J M, Smith, C, Harrison, C, Price, B P, Whiteley, M S]]></dc:creator>
<dc:date>2008-07-28</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.081001</dc:identifier>
<dc:title><![CDATA[Spring meeting of the Venous Forum at The Royal Society of Medicine, 3-4 April 2008]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>202</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>196</prism:startingPage>
<prism:section>Venous Forum Abstracts</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/101?rss=1">
<title><![CDATA[Practical advice for the treatment of venous disease in the elderly]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/101?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[O'Hare, J L, Earnshaw, J J]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007080</dc:identifier>
<dc:title><![CDATA[Practical advice for the treatment of venous disease in the elderly]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>102</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>101</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/103?rss=1">
<title><![CDATA[Epidemiology of chronic venous disease]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/103?rss=1</link>
<description><![CDATA[
<p>Chronic venous disease of the legs occurs commonly in the general population in the Western world. Estimates of the prevalence of varicose veins vary widely from 2&ndash;56% in men and from 1&ndash;60% in women. These variations reflect differences in variability of study populations including age, race and gender, methods of measurement and disease definition. Definitions of chronic venous disease may rely on reports of varicose veins by study participants, based on self-diagnosis or recall of a diagnosis, or on a standardized physical examination. Venous ulceration is less common, affecting approximately 0.3% of the adult population. Age and pregnancy have been established as risk factors for developing varicose veins. Evidence on other risk factors for venous disease is inconclusive. Prolonged standing has been proposed, but results of studies should be interpreted with caution given the difficulty in measuring levels of posture. Obesity has been suggested as a risk factor in women, but appears to be an aggravating factor rather than a primary cause. Other postulated risk factors include dietary intake and smoking, but evidence is lacking. Longitudinal studies using standardized methods of evaluation are required before the true incidence of chronic venous disease and associated risk factors can be determined.</p>
]]></description>
<dc:creator><![CDATA[Robertson, L, Evans, C, Fowkes, F G R]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007061</dc:identifier>
<dc:title><![CDATA[Epidemiology of chronic venous disease]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>111</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>103</prism:startingPage>
<prism:section>Venous Disease A-Z series: no. 4</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/112?rss=1">
<title><![CDATA[The effect of endovenous laser ablation on restless legs syndrome]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/112?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Venous disease was proposed as a cause of restless legs syndrome (RLS) by Dr Karl A Ekbom in 1944, but has since remained largely unexplored. This study examines the effect of endovenous laser ablation (ELA) in patients with concurrent RLS and duplex-proven superficial venous insufficiency (SVI).</p>
</sec>
<sec><st>Methods</st>
<p>Thirty-five patients with moderate to very severe RLS (as defined by the 2003 National Institute of Health (NIH) RLS criteria) and duplex-proven SVI completed an international RLS rating scale questionnaire (IRLS) and underwent standard duplex examination to objectively measure the baseline severity of their conditions. They were separated into non-operative and operative cohorts. The operative cohort underwent ELA of refluxing superficial axial veins using the CoolTouch CTEV 1320&nbsp;nm laser and ultrasound-guided sclerotherapy of the associated varicose veins with foamed sodium tetradecyl sulphate (STS). All patients then completed a follow-up IRLS questionnaire. Baseline and follow-up IRLS scores were compared.</p>
</sec>
<sec><st>Results</st>
<p>Operative correction of the SVI decreased the mean IRLS score by 21.4 points from 26.9 to 5.5, corresponding to an average of 80% improvement in symptoms. A total of 89% of patients enjoyed a decrease in their score of &ge;15 points. Fifty-three percent of patients had a follow-up score of &le;5, indicating their symptoms had been largely alleviated and 31% had a follow-up score of zero, indicating a complete relief of RLS symptoms.</p>
</sec>
<sec><st>Conclusions</st>
<p>ELA of refluxing axial veins with the CTEV 1320 nm laser and foamed STS sclerotherapy of associated varicosities alleviates RLS symptoms in patients with SVI and moderate to very severe RLS.</p>
</sec>
<sec><st>Recommendations</st>
<p>SVI should be ruled-out in all patients with RLS before initiation or continuation of drug therapy.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hayes, C A, Kingsley, J R, Hamby, K R, Carlow, J]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007051</dc:identifier>
<dc:title><![CDATA[The effect of endovenous laser ablation on restless legs syndrome]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>117</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>112</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/118?rss=1">
<title><![CDATA[Aminaphtone in idiopathic cyclic oedema syndrome]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/118?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Idiopathic cyclic oedema syndrome is a group of clinical conditions that exhibit a vascular capillary hyperpermeability accompanied by oedema caused by the interstitial retention of fluid. The objective of the current study was to evaluate the efficacy of aminaphtone in the treatment of idiopathic cyclic oedema.</p>
</sec>
<sec><st>Methods</st>
<p>A total of 15 female patients with clinical diagnosis of idiopathic cyclic oedema and aged between 22 and 49 years and a mean of 37.7 years were evaluated. After diagnosis, the patients were submitted to lower limb volumetry and asked to record the weight in the morning and evening at fixed times. One tablet of aminaphtone was prescribed every 8 h and on the fifth day the patients were reassessed. Percentages and the paired <I>t</I>-test were utilized for statistical analysis, with an alpha error of 5% considered acceptable (<I>P</I> value &lt;0.05).</p>
</sec>
<sec><st>Results</st>
<p>A significant reduction in limb size was detected after treatment using aminaphtone (<I>P</I> value &lt;0.0001) with losses between 9 g and 370 g, and an average loss of 116.9 g. Variations in weights in the morning and evening were significant (<I>P</I> value &lt;0.00001) with a maximum difference of 3 kg and a minimum of 120 g. Improvements were reported for 70% of patients.</p>
</sec>
<sec><st>Conclusion</st>
<p>Aminaphtone is efficacious in the reduction of oedema in patients with idiopathic cyclic oedema.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pereira de Godoy, J M]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007054</dc:identifier>
<dc:title><![CDATA[Aminaphtone in idiopathic cyclic oedema syndrome]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>119</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>118</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/120?rss=1">
<title><![CDATA[Correlation of haemodynamics and ankle mobility with clinical classes of clinical, aetiological, anatomical and pathological classification in venous disease]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/120?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To correlate venous haemodynamic parameters of lower limbs and amplitude of ankle mobility with the clinical, aetiological, anatomical and pathological classification (CEAP) for venous disease.</p>
</sec>
<sec><st>Methods</st>
<p>Two hundred and eighty-four lower limbs of 142 Caucasian women were evaluated and distributed in six groups according to the CEAP classification: Group I = C0 and C1 (<I>n</I> = 24); Group II = C2 (<I>n</I> = 30); Group III = C3 (<I>n</I> = 27); Group IV = C4 (<I>n</I> = 23); Group V = C5 (<I>n</I> = 20) and Group VI = C6 (<I>n</I> = 18). Goniometric examinations of ankle joints and air plethysmography (APG) were performed. Analysis of variance and the Bonferroni correction, Kruskal-Wallis' non-parametric and Dunn tests were utilized for statistical analysis with the level of significance being set at 5% (<I>P</I> value &lt; 0.05).</p>
</sec>
<sec><st>Results</st>
<p>There were significant restrictions in ankle mobility seen by goniometry at the C5 stage. In addition, significant changes in the venous-filling index were identified at C2, changes in the ejection fraction at C4 and changes in the residual volume fraction at the C4 stage.</p>
</sec>
<sec><st>Conclusion</st>
<p>The evolution of the clinical state of ankles affected by venous diseases is correlated to a reduction of joint mobility and haemodynamic alterations identified using APG.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Cavalheri, G, de Godoy, J M P, Belczak, C E Q]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007039</dc:identifier>
<dc:title><![CDATA[Correlation of haemodynamics and ankle mobility with clinical classes of clinical, aetiological, anatomical and pathological classification in venous disease]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>124</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>120</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/125?rss=1">
<title><![CDATA[Comparing results of digital photoplethysmography in two groups of chronic obstructive pulmonary disease patients with and without high pulmonary artery pressure]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/125?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Digital photoplethysmography (D-PPG) is a newly introduced method of optical screening of deep vein thrombosis (DVT) by recording changes in the size of limb due to tissue fluid.</p>
</sec>
<sec><st>Objectives</st>
<p>The objective of this study is to assess the effect of high pulmonary artery pressure (PAP) and consequently increased venous system pressure on D-PPG test results.</p>
</sec>
<sec><st>Methods</st>
<p>Forty-five patients with and 45 patients without PAP pressure were enrolled in the study and divided into two groups. All the patients had a history of chronic obstructive pulmonary disease (COPD). D-PPG test was performed for both legs of all the patients and the results of the two groups were compared. Also, all patients underwent duplex sonography for ruling out DVT.</p>
</sec>
<sec><st>Results</st>
<p>Using venous refilling time (RT) of &lt;22 s as the optimal cut-off point, it was found that 32 (35%) legs of patients with and 39 (43%) legs of patients without high PAP had positive D-PPG test. Although the rate of positive D-PPG test was higher in patients with high PAP, this was not statistically significant (<I>P</I> = 0.28). Moreover, overall correlation between RT and venous pump detected by D-PPG and PAP was <I>r</I> = &ndash;0.11 (<I>P</I> = 0.2) and <I>r</I> = &ndash;0.01 (<I>P</I> = 0.6), respectively.</p>
</sec>
<sec><st>Conclusion</st>
<p>Our results showed that the rate of positive D-PPG test results is slightly higher in patients with pulmonary hypertension, but this difference is not statistically significant. Therefore, increased PAP could be excluded as a confounding factor of D-PPG test.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Sharif-Kashani, B, Behzadnia, N, Shahabi, P]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2008.007084</dc:identifier>
<dc:title><![CDATA[Comparing results of digital photoplethysmography in two groups of chronic obstructive pulmonary disease patients with and without high pulmonary artery pressure]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>129</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>125</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/130?rss=1">
<title><![CDATA[Significance of limb trauma as an initiating factor in chronic leg ulceration]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/130?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To assess differences in clinical outcomes between patients with traumatic and spontaneous leg ulcers.</p>
</sec>
<sec><st>Methods</st>
<p>Consecutive leg ulcer follow-up patients seen between April 2004 and October 2005 in a specialist leg ulcer clinic were asked about the mechanism of the original ulceration. Twenty-four-week healing and 12-month recurrence rates were calculated using Kaplan-Meier analysis and outcomes were compared between groups with traumatic and spontaneous ulcers.</p>
</sec>
<sec><st>Results</st>
<p>Of the 300 patients assessed, 38 were excluded (incomplete data). In the remaining 262 patients, cause of ulceration was traumatic in 116/262 (44%) and spontaneous in 146/262 (56%). Age, ankle brachial pressure index &lt;0.85 and venous reflux were equally distributed between groups with traumatic and spontaneous ulcers (<I>P</I> = 0.470, 0.793, 0.965 respectively, Chi-square test). Twenty-four-week healing rates were 81% for traumatic and 67% for spontaneous ulcers (<I>P</I> = 0.015, Log-Rank test). Twelve-month recurrence rates were 32% for traumatic and 33% for spontaneous ulcers (<I>P</I> = 0.970, Log-rank test). Patients with traumatic ulcers suffered a total of 53 ulcer recurrences (median 0, range 0&ndash;4) compared with 89 in patients with spontaneous ulcers (median 0, range 0&ndash;8) (<I>P</I> &lt; 0.001, Mann-Whitney U test).</p>
</sec>
<sec><st>Conclusion</st>
<p>Approximately half of all leg ulcer patients recall a traumatic event. When managed in leg ulcer clinic, traumatic ulcers heal faster and recur less frequently than spontaneous ulcers.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Kulkarni, S R, Gohel, M S, Whyman, M R, Poskitt, K R]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007024</dc:identifier>
<dc:title><![CDATA[Significance of limb trauma as an initiating factor in chronic leg ulceration]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>136</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>130</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/137?rss=1">
<title><![CDATA[Is arteriovenous shunting involved in the development of varicosities? A study of the intraluminal pressure and oxygen content in varicose veins]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/137?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Arteriovenous (AV) shunting has been postulated as the underlying cause of varicose veins. The aim of this study was to analyse pressure and oxygen content in primary varicose veins in order to determine evidence of arterial shunting.</p>
</sec>
<sec><st>Methods</st>
<p>Thirty-nine patients with varicose veins underwent cannulation of varicosities. The pressure and the blood oxygen content within varicosities were measured in different positions and during exercise. Similar measurements were made in the long saphenous veins of 10 control subjects without venous disease.</p>
</sec>
<sec><st>Results</st>
<p>Mean pressure in varicose veins in the supine position was 12.3 mmHg (Standard deviation [SD] 3.6 mmHg). Control subjects had similar pressures measured in the long saphenous vein. No pulsatile pressure tracings were obtained. Varicosity pressures in the erect position averaged 66 mmHg (SD 9 mmHg). In all cases, the pressure correlated with the distance of the varicosity from the heart. Pressure reduction in varicosities after exercise was significantly less than that in control subjects. Recovery time (RT 90) was also significantly shorter than in the control group. Mean venous pO<SUB>2</SUB> in varicosities was 4.5 kPa (SD 1.0) in the supine position dropping to 3.9 kPa (SD 0.9) on standing; these values were not significantly different to samples from control subjects.</p>
</sec>
<sec><st>Conclusions</st>
<p>AV shunting is unlikely to be a causative factor in the development of primary varicose veins.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Murphy, M A, Hands, L]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007070</dc:identifier>
<dc:title><![CDATA[Is arteriovenous shunting involved in the development of varicosities? A study of the intraluminal pressure and oxygen content in varicose veins]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>141</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>137</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

<item rdf:about="http://phleb.rsmjournals.com/cgi/content/short/23/3/142?rss=1">
<title><![CDATA[Arterial disease but not hypertension predisposes to varicose veins]]></title>
<link>http://phleb.rsmjournals.com/cgi/content/short/23/3/142?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The aim of the study was to find out if persons with cardiovascular diseases (CVD) (arterial disease or hypertension) have additional risk of varicose veins (VV) compared with those without arterial disease (AD) or hypertension.</p>
</sec>
<sec><st>Methods</st>
<p>We studied, using a validated questionnaire, the prevalence and incidence of VVs in those with and without CVD in a population of 4903 including 40-, 50- and 60-year-old men and women in Tampere, Finland. During the five years of follow-up, we had a special interest on the appearance of new VVs in those without VVs at entry (<I>n</I> = 3065).</p>
</sec>
<sec><st>Results</st>
<p>We found a higher prevalence of VVs in persons with CVD than in those without CVD (with sex and age adjusted odds ratio [OR] 1.3 [95% confidence interval, CI 1.1&ndash;1.5]). The prevalence of VVs was higher in persons with AD (OR 1.7 [CI 1.4&ndash;2.2]), but not in persons with hypertension (OR 1.1 [CI 0.9&ndash;1.2]) than in those who were free of AD or hypertension, respectively. Subjects with AD had higher incidence of VVs (incidence odds ratio, IOR 1.4 [CI 0.8&ndash;2.7]) than subjects without AD and the effect was statistically significant in women (IOR 2.2 [CI 1.1&ndash;4.5]). Also the incidence of VVs was more affected by AD than by hypertension (IOR 1.1 [CI 0.7&ndash;1.8]).</p>
</sec>
<sec><st>Conclusion</st>
<p>There seems to exist a relatively strong additional risk of VVs in persons with AD and practically none in those with hypertension compared to those without.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Makivaara, L A, Ahti, T M, Luukkaala, T, Hakama, M, Laurikka, J O]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:identifier>info:doi/10.1258/phleb.2007.007058</dc:identifier>
<dc:title><![CDATA[Arterial disease but not hypertension predisposes to varicose veins]]></dc:title>
<dc:publisher>American College of Phlebology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>146</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>142</prism:startingPage>
<prism:section>Original articles</prism:section>
</item>

</rdf:RDF>